文献速递瘢痕与激光创面修复

儿童复发性瘢痕疙瘩术后放疗:病例系列与系统评价

The Role of Radiation Therapy in Pediatric Keloid Management: Case Series and Systematic Review.
PubMed 文献 · Ann Plast Surg · 2026-01-26

本研究通过回顾性病例系列(2000–2024年费城儿童医院)和系统评价(2025年3月,PRISMA),汇总5项已发表研究和1个机构系列共60例患者85个瘢痕疙瘩,评估儿童复发性瘢痕疙瘩再切除术后放疗的疗效与安全性。总体复发率为22.4%,常见不良反应为色素沉着(53.3%)和暂时性瘙痒(15.0%),未观察到继发恶性肿瘤或生长障碍。结论认为术后放疗可能有效,但需长期前瞻性研究验证持久性和肿瘤安全性。

要点

  • 儿童复发性瘢痕疙瘩再切除术后放疗总体复发率22.4%。
  • 常见不良反应为色素沉着(53.3%)和暂时性瘙痒(15.0%)。
  • 平均随访32.3±24.0个月,未见继发恶性肿瘤或生长障碍。

核心结论

  • 再切除术后放疗可能有效治疗儿童复发性瘢痕疙瘩。
  • 需长期前瞻性研究评估持久性和远期肿瘤安全性。

研究设计与样本

  • 回顾性病例系列:2000–2024年费城儿童医院接受再切除术后放疗的儿童复发性瘢痕疙瘩患者。
  • 系统评价:2025年3月按PRISMA指南检索,使用Oxford证据等级评估质量。
  • 共纳入5项已发表研究和1个机构系列,合计60例患者、85个瘢痕疙瘩,平均年龄14.4±3.5岁。

主要发现

  • 病变最常见于耳垂(38.3%)。
  • 主要放疗方式为近距离放疗(53.3%)和外照射放疗(46.7%),最常用方案为12 Gy分3次,通常在术后24小时内实施。
  • 辅助治疗包括皮质类固醇(21.7%)和压迫治疗(20.0%)。
  • 总体复发率22.4%。
  • 色素沉着(53.3%)和暂时性瘙痒(15.0%)为常见不良反应;平均随访32.3±24.0个月,未观察到继发恶性肿瘤或生长障碍。

关键数值与推荐

  • 复发定义为临床证据显示瘢痕超出瘢痕边界再生。
  • 最常用放疗方案为12 Gy分3次,通常在术后24小时内进行。

临床怎么用

  • 对儿童复发性瘢痕疙瘩,再切除术后24小时内放疗可作为可选方案。
  • 应告知色素沉着和暂时性瘙痒等常见不良反应。
  • 长期肿瘤安全性仍需前瞻性研究确认,当前证据不足以常规推荐。

局限性

  • 回顾性设计及纳入研究数量有限(5项发表研究+1机构系列)。
  • 平均随访32.3±24.0个月,不足以评估远期继发恶性肿瘤风险。
  • 需长期前瞻性研究验证持久性和肿瘤安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Radiation therapy following surgical excision is an effective strategy for recurrent keloids in adults. However, concerns about radiation-induced malignancy in children have limited its use and study in younger populations. This study aimed to assess clinical outcomes of postoperative radiation for recurrent pediatric keloids through a pooled literature analysis and review of our institutional experience. METHODS: A retrospective review was conducted of all pediatric patients treated at the Children's Hospital of Philadelphia from 2000 to 2024 who underwent reexcision followed by postoperative radiation for recurrent keloids. Recurrence was defined as clinical evidence of regrowth beyond scar borders. A systematic review was also performed in March 2025 in accordance with PRISMA guidelines, using terms related to "keloid," "radiation," and "pediatric." Studies' eligibility criteria were assessed for quality using the Oxford Levels of Evidence. RESULTS: Five published studies and 1 institutional series comprising 60 patients and 85 keloids were included (mean age, 14.4 ± 3.5 years). Most lesions were on the earlobes (38.3%). Brachytherapy (53.3%) and external beam radiation (46.7%), most commonly at 12 Gy in 3 fractions, were the primary modalities, typically delivered within 24 hours postoperatively. Adjunctive treatments included corticosteroids (21.7%) and compression therapy (20.0%). Overall recurrence was 22.4%. Hyperpigmentation (53.3%) and transient pruritus (15.0%) were common side effects. No cases of secondary malignancy or growth disturbance were observed (mean follow-up, 32.3 ± 24.0 months). CONCLUSION: Postoperative radiation following reexcision may serve as an effective treatment for recurrent pediatric keloids. Further long-term prospective studies are warranted to evaluate durability and oncologic safety in the long term.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Hu AC, Ryan IA, Tolley PD, et al. The Role of Radiation Therapy in Pediatric Keloid Management: Case Series and Systematic Review. Ann Plast Surg. 2026. PMID: 41587427. doi:10.1097/SAP.0000000000004629

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。